CHIR-99021 (CT99021) HCl

Catalog No.S2924

CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM in cell-free assays; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.

Price Stock Quantity  
USD 340 In stock
USD 90 In stock
USD 170 In stock
USD 570 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

CHIR-99021 (CT99021) HCl Chemical Structure

CHIR-99021 (CT99021) HCl Chemical Structure
Molecular Weight: 501.8

Validation & Quality Control

Cited by 66 publications:

7 customer reviews :

Quality Control & MSDS

Related Compound Libraries

CHIR-99021 (CT99021) HCl is available in the following compound libraries:

GSK-3 Inhibitors with Unique Features

  • Selective GSK-3 Inhibitor

    TWS119 GSK-3β-selective, IC50 of 30 nM.

  • Most Potent GSK-3 Inhibitor

    CHIR-98014 GSK-3α, IC50=0.65 nM; GSK-3β, IC50=0.58 nM.

  • GSK-3 Inhibitor in Clinical Trial

    Tideglusib Phase II for Alzheimer's disease.

  • Newest GSK-3 Inhibitor

    AZD1080 Orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively.

Product Information

  • Compare GSK-3 Inhibitors
    Compare GSK-3 Products
  • Research Area
  • Inhibition Profile

Product Description

Biological Activity

Description CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM in cell-free assays; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.
Targets GSK-3β [1]
(Cell-free assay)
GSK-3α [1]
(Cell-free assay)
Tie-2 [1]
(Cell-free assay)
FLT1 [1]
(Cell-free assay)

 View  More

IC50 6.7 nM 10 nM >5 μM >5 μM
In vitro CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Furthermore, CHIR-99021 shows only weak binding to a panel of 22 pharmacologically relevant receptors and little inhibitory activity against a panel of 23 nonkinase enzymes. CHIR-99021 induces the activation of glycogen synthase (GS) in insulin receptor-expressing CHO-IR cells with EC50 of 0.763 μM. [1] In addition to simulating the actions of insulin, inhibition of GSK-3 by CHIR-99021 (3 μM) increases free cytosolic β-catenin by 1.9-fold, mimicking the canonical Wnt signaling pathway in 3T3-L1 preadipocytes. During any of the first 3 days of differentiation, CHIR-99021 treatment inhibits the preadipocyte differentiation with IC50 of 0.3 μM by blocking induction of CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). [2] Unlike lithium chloride and AR-A014418, CHIR-99021 treatment does not reduce the viability of INS-1E cells even at high concentrations. Instead, CHIR-99021 robustly increases the rate of proliferation of INS-1E cells in a dose-dependent manner, and significantly inhibits INS-E cell death induced by high glucose and high palmitate in a concentration-dependent manner. CHIR-99021 promotes primary beta cell replication in isolated rat islets at concentrations as low as 1 μM, with 2-3 fold increase of cell replication at 5 μM of CHIR-99021 treatment. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
3T3-L1NGnuXXZHfW6ldHnvckBCe3OjeR?=MoPzN{DPxE1?NXjmdIRNPCCqMYTEUXNQMVHJcohq[mm2czDwdoVi\Gmyb3P5eIUh\GmoZnXy[Y51cWG2aX;uNYKyU2JwOTJyNUWyNFA>
insulin receptor–expressing CHO-IRMoXqSpVv[3Srb36gRZN{[Xl?NIGyXWU2ODBibl2=MUKzNEBucW5?Ml;pSG1UVw>?MWDBZ5RqfmG2ZYOgS4x6[2:pZX6gV5lvfGijc3WgLGdUMQ>?MlvvNVI3ODZ2OUe=
H4IIEMYPGeY5kfGmxbjDBd5NigQ>?NGXEcm0yOCEQvF2=M1jid|I1KGh?M2jsdGROW09?MWLS[Yd2dGG2ZYOg{tIu[2G2ZX7pckBi[3Srdnn0fUBidmRiVFnSSUBkd262YXnubY5oKHC{b33veIVzKGGldHn2bZR6Mn:2NVU{PTBzOUW=
Oct4/Sox2/Klf4-infected MEFsNUTBNZBRTnWwY4Tpc44hSXO|YYm=NVXJXlJ3OTBizszNMkfTNlgh\A>?NHnKeotFVVORNXXYcHgyWHKxbX;0[ZMhVUWIczDy[ZBzd2e{YX3tbY5oKFS{YX7z[JVk\WRiYomgU4N1PCxiU3;4Nkwh[W6mIFvs[lQ>M13mfFE6QDN7MEW1
Sca-1+ HPCMlnHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfVNkDPxE1?MVK2JIQ>MlznSG1UVw>?MVnTfY5memerc4TpZ4FtdHlicILvcY91\XNiU3PhMVEsyqCKUFOgdJJwdGmoZYLheIlwdiCjbnSgZ49td267IH\vdo1ifGmxbjD0c4dmfGincjD3bZRpKEWJRh?=NIX6TGMzOTZ{NEO0PC=>
HMC1.2M1noVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWezNEDPxE1?MkXJO|IhcA>?M1zk[2ROW09?NUPzfZdUWmWmdXPld{Bk\WyuIIP1dpZqfmGuMUOyNlA{QTNyMR?=
Endothelial cell(EC)MmDESpVv[3Srb36gRZN{[Xl?MUOzJO69VQ>?NXnL[41FTE2VTx?=MWTQdo9ud3SnczDlcoRwfGinbHnhcEBk\WyuIDjFR{kh\GmoZnXy[Y51cWG2aX;uM2n6XVIzODV{MEC2
PANC1NGjBSZhCeG:ydH;zbZMhSXO|YYm=MoGyxsA2KM7:TR?=M2TnPVczKGh?MlLtSG1UVw>?NYPHZYZFXHKrZ3fldpMh[W5iYYDvdJRwfGmlIILld5BwdnOnM1;UdVIzOjBzMUi2
INS-1EMWjGeY5kfGmxbjDBd5NigQ>?MnrBNk42KM7:TR?=M163NFI1KGh?NGP0V25FVVORMXrJcoR2[2W|IHGgdoVlfWO2aX;uJI9nKE6SMTDveoVz\XiycnXzd4lwdg>?MWqyNlQzPzdyNB?=
hiPSC-NPsMlHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1zpblPjiIoQvF2=NIrINFE4OiCqMmrHSG1UVw>?NYjL[ohzUW6lcnXhd4V{KGOnbHygdJJwdGmoZYLheIlwdsLiM3v3fVIzPjR{Nki3
plateletsMmPLSpVv[3Srb36gRZN{[Xl?NHSzUm4yOCEQvF2=MmHuNVUhdWmwM2rZdmROW09?MV;JcoNz\WG|ZYOgeIhzd22kaX6tcYVlcWG2ZXSgdIxifGWuZYSgZYdoemWpYYTpc44h[W6mIFHUVEB{\WO{ZYTpc44>NFL1fGkzOzJ|OUi3Oy=>
DN3NFnYZ5VHfW6ldHnvckBCe3OjeR?=NIjwU2wyOCEQvF2=NXzLcYFEQTZiaB?=MmjjSG1UVw>?NGLqSoZKdmO{ZXHz[ZMh[2WubDDk[ZZmdG:ybXXueEBidmRicILvcIln\XKjdHnvci=>M3Kx[lI{PTJ4OUi5
embryonic stem cells (ESC)MlS0SpVv[3Srb36gRZN{[Xl?NEXrN3c{KML3TR?=NVrIe|BEOTFiZB?=NETuO|RFVVORNX\kWVdvWHKxbX;0[ZMhe2WuZj3y[Y5mf2GuIH;mJI5iy6:4ZT30fZBmKG2xdYPlJIVu[nK7b37pZ{B{fGWvIHPlcIx{KCiHU1OpMkjINlM5PDN|MUK=
H460M2q4OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfhOUDDvU1?M2jvcFI1KGh?M3vuUGROW09?NEDx[GZRem:vb4Tld{Bk\WyuIIDyc4xq\mW{YYTpc44>NX;lUoxMOjR|Nke2PFg>
H157NFLXSFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk\lOUDDvU1?M{HiTFI1KGh?M13qcWROW09?NGPhc49Rem:vb4Tld{Bk\WyuIIDyc4xq\mW{YYTpc44>Mn;hNlQ{Pjd4OEi=
H460NFr4co5CeG:ydH;zbZMhSXO|YYm=NUPPS2lsPSEEtV2=NXviTWN5OjRiaB?=M4jZOWROW09?Mmq4RZR1\W63YYTld{Bk\WyuIHHwc5B1d3Orcx?=MX[yOFM3PzZ6OB?=
H157MYPBdI9xfG:|aYOgRZN{[Xl?M2PqTFUhyrWPMV6yOEBpM{\JRmROW09?NFH5NmJFd2W|IH7veEB{cWewaX\pZ4FvfGy7IHHm[oVkfCCjcH;weI9{cXN?MkfSNlQ{Pjd4OEi=
A549NXniNHlHSXCxcITvd4l{KEG|c3H5MnyyOUDDvU1?NX7XRYE1OjRiaB?=NF3ER5JFVVORNUDldVZ2UW6lcnXhd4V{KGOnbHygZZBweHSxc3nzNFfnOY8zPDN4N{[4PC=>
Neural progenitor cellsMkHmSpVv[3Srb36gRZN{[Xl?M3P4PFMh|ryPNYe2VW5oOTBiZB?=NITZTFRFVVORMmfaTY5lfWOnczDn[Y5memG2aX;uJI9nKG6ndYLhcEBxem:pZX7peI9zKGOnbHzzNYnteHV4OjR4M{iwN|Q>
ES-D3NVLMNYx7S3m2b4TvfIlkKEG|c3H5MmHoNVDDqM7:TR?=M2rqZ|Mh\A>?M2fLVWROW09?MlnETY5lfWOnczDtc4RmemG2ZTDjfZRwfG:6aXPpeJkhf2m2aDDJR|UxKG:oIESuPUDPxE1?NXm1WYw2OjR5N{mzOlU>
ES-CCENYS1[XFYS3m2b4TvfIlkKEG|c3H5MkfmNVDDqM7:TR?=MnnZN{BlMXTEUXNQNU[1RVRVUW6mdXPld{Bud2SncnH0[UBkgXSxdH;4bYNqfHl?Ml\rNlQ4Pzl|NkW=
ES-D3NHizT|lHfW6ldHnvckBCe3OjeR?=NIXweY42yqEQvF2=MYizJIQ>NVPrXIFkTE2VTx?=M3PBcnN1em:wZ3z5JIlv\HWlZYOgeIhmKGGldHn2bZR6KG:oIGfueE9j\XSjLXPheIVvcW5icHH0bJdigQ>?NVzOVXpEOjR5N{mzOlU>
ES-CCENX7tdmRHTnWwY4Tpc44hSXO|YYm=MmPDOeKh|ryPMmDPN{BlNF3WSmxFVVORMULTeJJwdmeueTDpcoR2[2W|IITo[UBi[3Srdnn0fUBw\iCZboSvZoV1[S2lYYTlcolvKHCjdHj3ZZk>NGrie5gzPDd5OUO2OS=>
SW982MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWfJR|UxRTBwMkG0NVYh|ryPNVXTUHlpW0GQR1XS
GCTNITsVIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlu1TWM2OD1yLkOwOlczKM7:TR?=MVvTRW5ITVJ?
769-PMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4T3cGlEPTB;MD61PFQ6QSEQvF2=Ml3WV2FPT0WU
LOXIMVINFnvZlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTBwNUi4N|Ih|ryPMlvUV2FPT0WU
D-336MGMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXX6Z411UUN3ME2wMlg1PjJizszNNWrPVlBqW0GQR1XS
S-117MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlz0TWM2OD1yLkmyNVMyKM7:TR?=M4n0fnNCVkeHUh?=
D-247MGMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17OZWlEPTB;MD65OFg2OiEQvF2=NGO1WYpUSU6JRWK=
TYK-nuNUPRbZpwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1W3cGlEPTB;MT6wO|kyOiEQvF2=MmeyV2FPT0WU
A498NUHPeZNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTFwM{C0Olkh|ryPMofSV2FPT0WU
BCPAPMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYC4PXJsUUN3ME2xMlY3QDl6IN88US=>M2f6W3NCVkeHUh?=
KYSE-180NFfFfHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTFwN{K3PFgh|ryPMVnTRW5ITVJ?
MIA-PaCa-2NVLIVJJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTFwN{W5O|ch|ryPNGnk[2pUSU6JRWK=
HCC1395MkjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTFwN{iyO|Mh|ryPMnrRV2FPT0WU
RS4-11NVW0dnBDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTFwOUW0NVUh|ryPM374SHNCVkeHUh?=
NCI-H2122NILCcmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVH4Nm9[UUN3ME2yMlI4Pjh2IN88US=>NF33[2NUSU6JRWK=
SNU-423MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TncGlEPTB;Mj60PVc5PyEQvF2=MWrTRW5ITVJ?
SK-LMS-1MnLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4DqcGlEPTB;Mj62OFEzQCEQvF2=MVHTRW5ITVJ?
RPMI-7951NVnBXGJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn74TWM2OD1{LkewNVk{KM7:TR?=M1;0[HNCVkeHUh?=
COLO-829NVzBR2x4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml:wTWM2OD1{Lke2OVQh|ryPM4H4eXNCVkeHUh?=
SCC-9Mm\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnXQTWM2OD1{Lkm1OFg2KM7:TR?=MVrTRW5ITVJ?
A704MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTNwMEixNkDPxE1?M1SzZ3NCVkeHUh?=
HOP-62MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWPSSYt{UUN3ME2zMlM3ODV2IN88US=>M1v3XXNCVkeHUh?=
HCC1569Mn70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnsTWM2OD1|LkS4N|A2KM7:TR?=MX\TRW5ITVJ?
A172NW\NcWtWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\wdWlEPTB;Mz63OVQ6QCEQvF2=Mk\QV2FPT0WU
MOLT-16NG\JW5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PkemlEPTB;Mz64PFU2PiEQvF2=NGW4Rm1USU6JRWK=
TE-15MljwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jPV2lEPTB;Mz65OVM1OyEQvF2=NV6ySXo2W0GQR1XS
OE19MlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHEPYdKSzVyPUOuPVY1PTFizszNMV\TRW5ITVJ?
MHH-ES-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV[5W4VRUUN3ME20MlA1PTR3IN88US=>NV;UZpVKW0GQR1XS
NKM-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrDSYJtUUN3ME20MlE{QTdzIN88US=>MX;TRW5ITVJ?
RCC10RGBMn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3j1R2lEPTB;ND6yPVQ4QSEQvF2=NX71XJBFW0GQR1XS
BxPC-3NWC5ZYZZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\4TWM2OD12LkewN|kyKM7:TR?=MY\TRW5ITVJ?
ALL-PONVvrOW11T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHuxOIVKSzVyPUSuPFM5PThizszNMVrTRW5ITVJ?
SK-OV-3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{m2N2lEPTB;ND65PVM1KM7:TR?=NYrub444W0GQR1XS
SW1710NFHKT|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPxUIdKSzVyPUWuOFI1PTZizszNNETueWVUSU6JRWK=
NCI-H2452M4O1e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4nGcGlEPTB;NT60OVYzQCEQvF2=M3rBdnNCVkeHUh?=
D-392MGM3WxUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTVwNEmxOFUh|ryPNU\KUWc{W0GQR1XS
LB2518-MELM2\yWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlT5TWM2OD13LkeyOlI4KM7:TR?=MW\TRW5ITVJ?
BL-41NXL5UHkzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LtOGlEPTB;NT64NVI3PiEQvF2=M1rFOHNCVkeHUh?=
WM-115MlTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XXb2lEPTB;NT64NVUxQSEQvF2=NX;EWJdoW0GQR1XS
SK-MEL-2NF;SVJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrDTWM2OD14LkO4N|Q1KM7:TR?=MVvTRW5ITVJ?
CGTH-W-1NF71d2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWTJR|UxRTZwNEG3JO69VQ>?MWnTRW5ITVJ?
BB65-RCCMmH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXm3UIpPUUN3ME22MlU{OTl3IN88US=>M2DoNXNCVkeHUh?=
CAL-85-1NXG5SIF7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnSelVKSzVyPU[uOlA6OzZizszNM{LscHNCVkeHUh?=
RT-112MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXmcYt1UUN3ME23MlE3PDV4IN88US=>NHvHXIRUSU6JRWK=
MC116NVjkNHcyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHYTWM2OD15LkK4OlkyKM7:TR?=MX7TRW5ITVJ?
G-361M1nzS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3[3e2lEPTB;Nz60OlU3OSEQvF2=M{fVWHNCVkeHUh?=
SW1417NInaUZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVG5S2VpUUN3ME23MlY1PTh2IN88US=>M1fvXnNCVkeHUh?=
MV-4-11MmexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mo\FTWM2OD16LkW0N|A1KM7:TR?=MWHTRW5ITVJ?
CAL-72NFPiR3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:1UIpKSzVyPUiuO|YyOTNizszNMXHTRW5ITVJ?
MKN28M3nCe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3vVJBOUUN3ME24Mlg5PTF4IN88US=>NVjkRXU4W0GQR1XS
MEG-01NUW0bJB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRThwOUmwOFMh|ryPM4\lW3NCVkeHUh?=
ACHNMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFfQVGpKSzVyPUmuN|A2PDZizszNNHvsco1USU6JRWK=
NCI-H1755NF61RXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUWx[5p{UUN3ME25MlM6QTh4IN88US=>Mom2V2FPT0WU
NCI-H64NEjtS2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jydWlEPTB;OT60NlI2PSEQvF2=Mn\TV2FPT0WU
COLO-205NFfIdHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nScmlEPTB;OT60N|gzOSEQvF2=NX;pbohpW0GQR1XS
CTV-1NI\BdZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWj6W2lkUUN3ME25MlQ{QDl2IN88US=>NHvSWXRUSU6JRWK=
U-2-OSMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml3PTWM2OD17LkS1NFA3KM7:TR?=NUnZeJE3W0GQR1XS
LB996-RCCNXLaOmNpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1TndGlEPTB;OT61NlM6PyEQvF2=M3HweXNCVkeHUh?=
SK-N-DZMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zWRmlEPTB;OT62OVc1OiEQvF2=MVTTRW5ITVJ?
EFM-19Mn7IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEX2[FBKSzVyPUmuO|U2PjZizszNMl[0V2FPT0WU
DBTRG-05MGM4PEVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1PNeGlEPTB;OT63O|c4KM7:TR?=MVnTRW5ITVJ?
U-118-MGMoPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFjXUIVKSzVyPUmuPVQ1PDRizszNNX7zPY5SW0GQR1XS
LB1047-RCCNFHBcnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUi2XlRIUUN3ME25Mlk6Pzl6IN88US=>M2nqN3NCVkeHUh?=
NCI-H28MoWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHmTWM2OD1zMD60OFE{KM7:TR?=NVTNR4VGW0GQR1XS
MZ2-MELMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTETWM2OD1zMD60Olc4KM7:TR?=NUnDRnNwW0GQR1XS
M059JMke4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPjTWM2OD1zMD62NVAzKM7:TR?=NHvNdVJUSU6JRWK=
HT-3NHXyXItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml:yTWM2OD1zMD62NVc6KM7:TR?=NV;K[WliW0GQR1XS
SNU-387M4O1[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnYNGtKSzVyPUGwMlczOzVizszNM3vZZXNCVkeHUh?=
NCI-H526MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLtRZVZUUN3ME2xNU4yOzZ3IN88US=>M{DMenNCVkeHUh?=
HELMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Moj3TWM2OD1zMT62OVc6KM7:TR?=MUnTRW5ITVJ?
PA-1MnvSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MorpTWM2OD1zMT65N{DPxE1?MWnTRW5ITVJ?
PC-14Mnz3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXzkT41HUUN3ME2xNk4{OjRizszNNXPEb5JTW0GQR1XS
C8166M4LpeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fjfGlEPTB;MUOuNlMyQCEQvF2=NWPhWYpCW0GQR1XS
NCI-H82M4j2fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HZfWlEPTB;MUOuNlkxQSEQvF2=NVnnW4tNW0GQR1XS
DSH1MmPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M371RmlEPTB;MUOuN|g4QSEQvF2=NWfmRXljW0GQR1XS
T98GM4\XZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PoSWlEPTB;MUOuOFcyPyEQvF2=MYHTRW5ITVJ?
KU812NF71NIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTF|LkWxO|Uh|ryPNXzkdmJGW0GQR1XS
SW48NVzWb4pIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIi0eFVKSzVyPUGzMlczPjVizszNNXvFVIdlW0GQR1XS
MEL-HONFXnUGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13QT2lEPTB;MUOuPFgzQSEQvF2=NUCxSnRnW0GQR1XS
SF539NVyye3NJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHLMW3pKSzVyPUG0MlAyOTZizszNM4DVfnNCVkeHUh?=
NB1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUfGPXZQUUN3ME2xOE4yQTN3IN88US=>NH3NZmRUSU6JRWK=
ST486M1P5dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlLHTWM2OD1zND6yNlUyKM7:TR?=M4\6THNCVkeHUh?=
LoVoNVPGUlBOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXP2fYtNUUN3ME2xOU4zPjV7IN88US=>NIPqfnJUSU6JRWK=
NH-12MlPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHDeIlKSzVyPUG2MlAxQTdizszNNGTreZlUSU6JRWK=
CCRF-CEMNGO0cI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmflTWM2OD1zNj62O|AzKM7:TR?=NWPsdVRkW0GQR1XS
DaudiNV3GOlhsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX3EfVdsUUN3ME2xO{43OTR7IN88US=>NX7mVGIxW0GQR1XS
SIMANVTMeHZUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\Ye4VKSzVyPUG3MlkyOThizszNMYHTRW5ITVJ?
8305CNH20TVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLHTWM2OD1zOD61N|A2KM7:TR?=M1jHPHNCVkeHUh?=
EM-2NFr2bplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Wz[2lEPTB;MUiuOlI1QCEQvF2=MnjYV2FPT0WU
SNU-449M2K4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVTNcZpIUUN3ME2xPE44OTVizszNMnTrV2FPT0WU
A101DNGq3b3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTF7LkK0N{DPxE1?NITUUFRUSU6JRWK=
MHH-NB-11MmTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTF7LkWzOFIh|ryPNIf1XVRUSU6JRWK=
BeckerNVvkTFY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXiNpFKSzVyPUKwMlE4PzdizszNMoPCV2FPT0WU
NCI-H727MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jENWlEPTB;MkCuNlE3QSEQvF2=NF\0UXZUSU6JRWK=
HCC1187NWHRTHNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTJyLkO1PFkh|ryPM1zh[HNCVkeHUh?=
KYSE-450M1TsU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTJzLkWzOVQh|ryPMkDnV2FPT0WU
SK-MEL-28NWfLcpVwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTJzLk[4OlMh|ryPNI\keZZUSU6JRWK=
BPH-1MoToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFi5PZhKSzVyPUKxMlcxOzVizszNMWrTRW5ITVJ?
EoL-1-MknvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTJzLkizPFUh|ryPNFLTbo5USU6JRWK=
TGBC24TKBM1exO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nNSmlEPTB;MkGuPFk2PyEQvF2=MofBV2FPT0WU
KARPAS-299M2fMWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXPcmFKSzVyPUKyMlE6PTRizszNNF;GcJFUSU6JRWK=
SW684NXLucJdDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1\CO2lEPTB;MkKuNlg2QCEQvF2=NYDoRlNwW0GQR1XS
RXF393NHXsVZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7qeVdKSzVyPUKyMlYxPjhizszNNVv4O41RW0GQR1XS
LS-513M1XxVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{CwbGlEPTB;MkKuOlE6OiEQvF2=MnzQV2FPT0WU
KURAMOCHINHT5cndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDRS4dRUUN3ME2yNk44ODZ7IN88US=>MV7TRW5ITVJ?
GI-1Mn\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nodmlEPTB;MkKuO|g1OSEQvF2=M4DZN3NCVkeHUh?=
M14NE\XfYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkP6TWM2OD1{Mz6xNVMzKM7:TR?=M2XHRXNCVkeHUh?=
REHM4HT[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vUfWlEPTB;MkOuNVY6QSEQvF2=M{DpWXNCVkeHUh?=
K5M2TvbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnv4TWM2OD1{Mz61OFg3KM7:TR?=NFzYdpBUSU6JRWK=
PANC-10-05Ml70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTJ2LkC4PVgh|ryPM2XRSXNCVkeHUh?=
HMV-IINET5R3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DuUmlEPTB;MkSuNlE3OyEQvF2=M4TFdnNCVkeHUh?=
NCI-H1963NFi4OnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoCwTWM2OD1{ND6yPFM6KM7:TR?=NITwSpZUSU6JRWK=
LU-139M{D6Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnP3TWM2OD1{ND64N|Uh|ryPMm\OV2FPT0WU
KASUMI-1MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTJ2LkmzNlgh|ryPM1\lcHNCVkeHUh?=
RO82-W-1NVPpO5BCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zpcmlEPTB;Mk[uO|M4PyEQvF2=NFXPVotUSU6JRWK=
NCI-H1770MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLWTWM2OD1{Nj64PVg3KM7:TR?=MWjTRW5ITVJ?
SNG-MM{O2e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEHGbXJKSzVyPUK3MlIzPzFizszNNVTsbXFqW0GQR1XS
KLEMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXH3dnFXUUN3ME2yO{4zPTZ3IN88US=>M3vjW3NCVkeHUh?=
NCI-H2170MlfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnvOopKSzVyPUK3MlUzQDJizszNMnj5V2FPT0WU
COLO-792MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjyS3VKSzVyPUK3Mlc4OjhizszNMYfTRW5ITVJ?
ES8MlLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPqVmtSUUN3ME2yO{44QDF2IN88US=>M4PhSHNCVkeHUh?=
MC-CARM{\yfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfXTWM2OD1{Nz63PVA4KM7:TR?=M1[xXHNCVkeHUh?=
SU-DHL-1NG\McGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFPubIlKSzVyPUK3Mlk1PzRizszNM1HoR3NCVkeHUh?=
OAW-28M2DxTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTJ6LkCwOVIh|ryPMU\TRW5ITVJ?
C32M{W0Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlf2TWM2OD1{OD6wPFI3KM7:TR?=MoPQV2FPT0WU
SW872M3rNTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHJTWM2OD1{OD61N|I3KM7:TR?=Ml;yV2FPT0WU
JiyoyeP-2003M4HnbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHHO3VbUUN3ME2yPU43PzF7IN88US=>MkTFV2FPT0WU
A204M3nrTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\pNG4yUUN3ME2yPU43QDJ6IN88US=>NU\6fYxxW0GQR1XS
IST-MES1NYDoUVhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPETWM2OD1{OT63NFkzKM7:TR?=NG[5TJpUSU6JRWK=
LCLC-103HNWXpT2h1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHIbmpKSzVyPUOwMlIxPTlizszNMl61V2FPT0WU
CAKI-1NVG3NFlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLEfnlFUUN3ME2zNE4zPjV4IN88US=>NF7nV4xUSU6JRWK=
NALM-6M{fQTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nQcmlEPTB;M{CuOFk3PSEQvF2=M{XE[HNCVkeHUh?=
SK-MM-2MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTNyLkm3PVIh|ryPM1\vXnNCVkeHUh?=
LB373-MEL-DM3HyXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\jTWM2OD1|MT6wNFQ4KM7:TR?=NV;uN|N2W0GQR1XS
CAS-1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDVUIdiUUN3ME2zNU44PjZ3IN88US=>Mmq1V2FPT0WU
KNS-42NF7GXW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnxOXFKSzVyPUOxMlg3PjJizszNNX\6WHFWW0GQR1XS
SW948MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEX1fIxKSzVyPUOyMlc2PDhizszNMXzTRW5ITVJ?
HCC1143MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\VTWM2OD1|Mj63PVc6KM7:TR?=MW\TRW5ITVJ?
NCI-H1648M1f2Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NViz[IdRUUN3ME2zNk45PDZ5IN88US=>NFW1TZlUSU6JRWK=
RVH-421MoXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3TBRmlEPTB;M{OuNVY5KM7:TR?=NIXiOHBUSU6JRWK=
KU-19-19MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlSxTWM2OD1|Mz63OVM1KM7:TR?=NUThWWZzW0GQR1XS
PFSK-1MknuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUfEUG54UUN3ME2zOE46OjRzIN88US=>NHq1O4dUSU6JRWK=
TK10M3jEO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHjYXYRKSzVyPUO1MlE{OjJizszNNXSwU2UxW0GQR1XS
IGROV-1NX2yXXMzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jnNmlEPTB;M{WuN|QyPiEQvF2=NHXIUWdUSU6JRWK=
EFE-184NXT2b4F6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTN3LkmxO{DPxE1?NEnpcpVUSU6JRWK=
8505CMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTN3LkmyPVQh|ryPM3rKZnNCVkeHUh?=
SK-UT-1Ml3VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTtTWM2OD1|Nj6zN|MyKM7:TR?=M3TadHNCVkeHUh?=
MKN1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTN4Lki0OFQh|ryPNE\MPVVUSU6JRWK=
no-10M4e4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmToTWM2OD1|OD6xNlk1KM7:TR?=M4PBW3NCVkeHUh?=
HT-144NYjZXYpYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3W3cWlEPTB;M{iuNlU4PSEQvF2=NXvRbXFPW0GQR1XS
CMKNHjPd2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M37K[mlEPTB;M{iuOFE3OiEQvF2=NVjNUHVwW0GQR1XS
KM12MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkDMTWM2OD1|OD61PVk5KM7:TR?=NEPjOYFUSU6JRWK=
HCC2218NUjz[FBLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jKcmlEPTB;NECuOVg1QSEQvF2=MVfTRW5ITVJ?
BE-13MmThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\4OmlEPTB;NEGuOFQ4OyEQvF2=MoSwV2FPT0WU
SK-CO-1M2r6c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrETWM2OD12MT63O|U2KM7:TR?=Mon5V2FPT0WU
MPP-89NHi5UJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVLQN4lZUUN3ME20NU46OjFzIN88US=>NH60[|BUSU6JRWK=
NYNFv0fIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWnwfGI5UUN3ME20Nk4yQDBzIN88US=>M4PQNXNCVkeHUh?=
IST-MEL1NGXZOYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTR{Lk[5N|gh|ryPMWHTRW5ITVJ?
HCT-116MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUS0XZJnUUN3ME20N{4zODl7IN88US=>MYTTRW5ITVJ?
LB831-BLCNYDkbGk1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTR|Lk[5O{DPxE1?M3HEenNCVkeHUh?=
TE-8M3zIU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTR|Lke4PVUh|ryPMn30V2FPT0WU
SRM2DrVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWK0TY1tUUN3ME20N{45Pjd|IN88US=>MmTjV2FPT0WU
ESS-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7XTWM2OD12ND6yNFYzKM7:TR?=NEXZOWdUSU6JRWK=
KYSE-270NU\yUFJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnn2TWM2OD12NT6wOFM4KM7:TR?=M{fVO3NCVkeHUh?=
H4MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3wcHJKSzVyPUS1MlMzQTZizszNNWLtSFJsW0GQR1XS
COLO-800NFvkO3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFz4[GtKSzVyPUS1MlU5QThizszNNUXRXXJuW0GQR1XS
Ramos-2G6-4C10MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M122XmlEPTB;NE[uNFc2PSEQvF2=M3q1NHNCVkeHUh?=
no-11NWrqWFdVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvjO4NEUUN3ME20Ok4zODNzIN88US=>MnXqV2FPT0WU
UACC-62MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHpTWM2OD12Nj64OlA5KM7:TR?=MlSzV2FPT0WU
D-542MGM2XiXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PQdWlEPTB;NEeuOFU5QSEQvF2=NVW2TmE6W0GQR1XS
NCI-H747MnOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHN[5VKSzVyPUS3MlczPjRizszNM4jCXXNCVkeHUh?=
HCC2998NVnPeolqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HLW2lEPTB;NEiuNlk5OiEQvF2=NWCyOWJiW0GQR1XS
SNB75M4fzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXUTWM2OD12OD60NVE5KM7:TR?=Mnv4V2FPT0WU
COR-L105M1XTR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYW5WYlUUUN3ME20PE46PzNizszNMUXTRW5ITVJ?
SNU-C1MnHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XT[mlEPTB;NEmuN|IxPyEQvF2=MV3TRW5ITVJ?
LC4-1NVfYS4RxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH3lV2xKSzVyPUS5Mlg6OTJizszNMmfDV2FPT0WU
KS-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XlTWlEPTB;NUCuNlIzPSEQvF2=M2jHR3NCVkeHUh?=
NCI-H1793M1HCWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\vTWM2OD13MT6yN|Eh|ryPMmHFV2FPT0WU
NCI-H1650NX\HV3FuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHLPVJRKSzVyPUWxMlU5PDlizszNNXy5XFV1W0GQR1XS
MCF7MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPVTWM2OD13MT63OVU1KM7:TR?=MmPHV2FPT0WU
SK-N-ASMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTVzLkiyPFEh|ryPNXnUdHU{W0GQR1XS
SW837NEPQO2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFn3V4xKSzVyPUWxMlk4QDVizszNNG\WV3RUSU6JRWK=
DBNHzseYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M330U2lEPTB;NUGuPVg2PSEQvF2=M4q5XXNCVkeHUh?=
CESSNYL5bnZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUi0RZdtUUN3ME21Nk4yPDVizszNMnrnV2FPT0WU
CHP-126M{XQXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF22ZWdKSzVyPUWzMlUyPjlizszNMV\TRW5ITVJ?
COLO-824MkLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLhTWM2OD13Mz62PVc3KM7:TR?=MlLUV2FPT0WU
MG-63NUPEV|VVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2SwVGlEPTB;NUOuPVM5OSEQvF2=NF20OFVUSU6JRWK=
KGNMkO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPrRlRTUUN3ME21N{46PTlizszNNHvLVmxUSU6JRWK=
697MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYfmWGhjUUN3ME21OE4yPTV3IN88US=>M2HKZ3NCVkeHUh?=
MC-IXCMmH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MonETWM2OD13ND60N|Y1KM7:TR?=NVfrUot[W0GQR1XS
A375NH3uXIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDYeXlKSzVyPUW0MlgxPTlizszNNFHVfo1USU6JRWK=
LXF-289M4HvNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTV3LkWwOlYh|ryPMUfTRW5ITVJ?
ES6NEe3dmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2XqemlEPTB;NUWuPFg6QSEQvF2=NFzOd|FUSU6JRWK=
DV-90MnfkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTV3Lki5NVch|ryPM3P4b3NCVkeHUh?=
RCM-1NEPnPZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVfneIFUUUN3ME21Ok4xODd6IN88US=>MWPTRW5ITVJ?
NCI-H2405NYrmN5V{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIDhdoJKSzVyPUW2MlE3QTNizszNM1\iTXNCVkeHUh?=
DoTc2-4510M1jHcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PLWGlEPTB;NU[uOlA2PyEQvF2=NUP1R5pxW0GQR1XS
RPMI-8866M4r0VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4\RPWlEPTB;NUeuNlQyOiEQvF2=NIr5V21USU6JRWK=
BV-173NGXXVWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIn0RotKSzVyPUW3MlUyPDJizszNMmXMV2FPT0WU
LCLC-97TM1NHS1OpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;qb2RKSzVyPUW5MlA2PTNizszNMYPTRW5ITVJ?
HT-1376M131SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2TocGlEPTB;NUmuNFkzOSEQvF2=NIX4b49USU6JRWK=
ACNNGrFXldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\JcHNlUUN3ME21PU4yPTh5IN88US=>NGH3dmJUSU6JRWK=
LU-134-AMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHfWblVKSzVyPUW5MlYxOTZizszNMYDTRW5ITVJ?
SiHaNUjIOYZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTV7Lk[0PFch|ryPNI\UbGhUSU6JRWK=
EKVXM{TvZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LmeGlEPTB;NkGuOFk2QCEQvF2=MULTRW5ITVJ?
NMC-G1M3\kPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTZzLkmyOFIh|ryPM3W3b3NCVkeHUh?=
NCI-H1734NUHaUlVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTZzLkm2OlMh|ryPM{L4ZnNCVkeHUh?=
K-562NV;Gb|B1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jaemlEPTB;NkKuNlQ2OiEQvF2=MWLTRW5ITVJ?
T-24MorHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTZ{LkexNlYh|ryPM1z0[HNCVkeHUh?=
SCHMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4ThRmlEPTB;NkSuNlM2OSEQvF2=NYLqc255W0GQR1XS
AN3-CANGrxSGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NILMRXBKSzVyPU[0MlMxOzVizszNNW\POVYyW0GQR1XS
MFE-296MmLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLjTWM2OD14ND60OFc{KM7:TR?=M{T1[HNCVkeHUh?=
HuCCT1M2LsWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTZ5LkCzO|Qh|ryPM1W1RnNCVkeHUh?=
NCI-H1703M1zLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1m1VmlEPTB;NkiuNVE4OSEQvF2=MlKyV2FPT0WU
C-4-IINHztc4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTZ7LkO2NFch|ryPNHn0UnpUSU6JRWK=
NCI-H2342MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEn6PZBKSzVyPU[5MlM6PjFizszNMUHTRW5ITVJ?
Hs-578-TNGLGenRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTdyLkOg{txOM2r0ZnNCVkeHUh?=
HCC1806NYjzfmdsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjSWlAxUUN3ME23NU41PTh5IN88US=>MoL0V2FPT0WU
EW-16M2T1Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo[0TWM2OD15MT63OFE2KM7:TR?=NIG2OFRUSU6JRWK=
KALS-1M2DXSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTd|LkW0O|Uh|ryPNEntWo9USU6JRWK=
RT4MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnXcXdKSzVyPUezMlU4PDJizszNMmnVV2FPT0WU
LS-411NNYCwVYVET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;wZWlEPTB;N{SuNlUzQCEQvF2=M3XGcHNCVkeHUh?=
SK-MEL-1NH2zeXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjWZldpUUN3ME23OU45ODF7IN88US=>NWDvNZVNW0GQR1XS
8-MG-BAMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTd4LkGwPVYh|ryPMVfTRW5ITVJ?
HSC-3NXPWTmZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnZRpFIUUN3ME23O{4xOjh{IN88US=>MWLTRW5ITVJ?
NB6MkH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWjacWJDUUN3ME23PE4yOjl7IN88US=>NG\ONnVUSU6JRWK=
PANC-03-27NFjpV45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\O[GlEPTB;N{iuOFM2KM7:TR?=NVH6SId[W0GQR1XS
KP-N-YSNX\teot6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLVTWM2OD15OD61PFc5KM7:TR?=NELwTmRUSU6JRWK=
SF295M{TMeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2LDeWlEPTB;N{muPVU2OyEQvF2=NXTtepUyW0GQR1XS
HCE-TMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETrfnRKSzVyPUiwMlE2QDhizszNM4\qbHNCVkeHUh?=
KYSE-410Mmf4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV6zeYtTUUN3ME24NE4zQDV5IN88US=>MonIV2FPT0WU
NB12M{ToSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDTU3hbUUN3ME24NE46OzZ7IN88US=>NXXIS4FIW0GQR1XS
NCI-H661MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjLWIdyUUN3ME24NU4{PDRizszNMWTTRW5ITVJ?
NCI-H1417NUf1PYJYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3v4PGlEPTB;OEGuOFM3QCEQvF2=NWXzb|JqW0GQR1XS
KMOE-2M2nJdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRThzLki1N|Eh|ryPNXe5WJAzW0GQR1XS
SW1573MlvGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3v5PGlEPTB;OEKuOVg6OyEQvF2=MVTTRW5ITVJ?
BFTC-905NULMVmJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPUOI5KSzVyPUi0MlAyPzJizszNMV\TRW5ITVJ?
SBC-1NGLBT49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{LIdGlEPTB;OESuNFIxQCEQvF2=NYPQUnl1W0GQR1XS
MDA-MB-175-VIIMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPwTWM2OD16NT63OFI3KM7:TR?=NXXyUoZTW0GQR1XS
TE-12NWfZOodMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHQdXVKSzVyPUi5MlM4PDFizszNM{[0VnNCVkeHUh?=
NCI-H650MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLnTWM2OD16OT64O|I1KM7:TR?=M{TTWHNCVkeHUh?=
C-33-AMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFi5UGFKSzVyPUmwMlU1KM7:TR?=NXraXIUzW0GQR1XS
MZ7-melMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTlzLkK2O|Yh|ryPM4LLXnNCVkeHUh?=
BOKUNWL5XVNJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGC4[VNKSzVyPUmyMlY6PTdizszNNXfFb3JpW0GQR1XS
CAL-33NYLYW4Y2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\TcmZKSzVyPUmzMlA3ODFizszNMWjTRW5ITVJ?
23132-87NWGzXIFqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVzmOJdTUUN3ME25N{4yPjhizszNNYnveWR2W0GQR1XS
J82NF\X[|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2fqWWlEPTB;OUOuO|gyOSEQvF2=MWrTRW5ITVJ?
MZ1-PCNEHyW|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTl2LkW5PFQh|ryPNHTreVRUSU6JRWK=
MEL-JUSOM3zaVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXpOnY3UUN3ME25OE46PTRizszNMonHV2FPT0WU
RMG-INEHIcVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\ZO5VKSzVyPUm1MlExPzJizszNMkT0V2FPT0WU
A2058NYX2WZJQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;kVG1mUUN3ME25OU41PjF5IN88US=>NGm0VYNUSU6JRWK=
Caov-4M4fjdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoSwTWM2OD17NT62PFUh|ryPM2DlV3NCVkeHUh?=
OS-RC-2MnrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXj4XG9KUUN3ME25O{41PjFizszNMVHTRW5ITVJ?
MKN7M4W3Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MljNTWM2OD17Nz63OFM6KM7:TR?=M4rBWXNCVkeHUh?=
U-698-MNEHYRpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3TNVWlEPTB;OUiuPVQ5QSEQvF2=M3n4VHNCVkeHUh?=
PC-3MoOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHfWSVlKSzVyPUm5MlA2PjRizszNMn7iV2FPT0WU
NCI-H292Mlf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fUc2lEPTB;OUmuN|AxPCEQvF2=NFvTOWpUSU6JRWK=
IGR-1NUfjWZVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TLR2lEPTB;OUmuN|EyQSEQvF2=NGfITFlUSU6JRWK=
MewoMonMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTl7LkW2NFMh|ryPM3z6enNCVkeHUh?=
LU-65M4K0U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NISw[lhKSzVyPUGwNU4xQDFizszNNVLqWnlxW0GQR1XS
Saos-2NGDiV|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGO5OWJKSzVyPUGwNU41OzdizszNM2\QOHNCVkeHUh?=
TE-11M1L1TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zvbmlEPTB;MUCxMlczPCEQvF2=MXzTRW5ITVJ?
SK-MES-1M3jtZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4e3VmlEPTB;MUCxMlc3OiEQvF2=MoH6V2FPT0WU
KE-37Ml70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXuTWM2OD1zMEKuPVUh|ryPM3f3bXNCVkeHUh?=
MKN45MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fh[WlEPTB;MUCzMlU5PCEQvF2=NIfWNHFUSU6JRWK=
UM-UC-3Mkj6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\5SlVKSzVyPUGwN{45PDJizszNNFXmfWJUSU6JRWK=
SNU-C2BMojHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV3hZmVjUUN3ME2xNFUvODJ|IN88US=>MVfTRW5ITVJ?
RPMI-8226MkPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7mZ21KSzVyPUGwOk43PzhizszNMn7qV2FPT0WU
PANC-08-13Mn7YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUe0[WkyUUN3ME2xNFYvQDVizszNMne1V2FPT0WU
NCI-H23NULoR2Z{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHqOGVKSzVyPUGwPE4{PTdizszNNEnCOGFUSU6JRWK=
HOP-92MoOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTFyOD60O|Uh|ryPMlvvV2FPT0WU
FTC-133NVXQ[ZRJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVz4fXZYUUN3ME2xNFgvPDh6IN88US=>M4jtb3NCVkeHUh?=
D-263MGMVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnH1TWM2OD1zMEiuPVYyKM7:TR?=NVzBT2dnW0GQR1XS
DU-145M3PPOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXnTWM2OD1zMEmuPVQ2KM7:TR?=NEP5[m1USU6JRWK=
A253NFLqcphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUHqRolTUUN3ME2xNVAvPDd7IN88US=>MnWwV2FPT0WU
HCT-15NYTKZYlxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTFzMD62OlEh|ryPM1:0dXNCVkeHUh?=
WSU-NHLMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zMSWlEPTB;MUGyMlAyKM7:TR?=Moe4V2FPT0WU
U031NELMNHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFPZ[JNKSzVyPUGxNk4xPjVizszNMkfkV2FPT0WU
MDA-MB-157Mm\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlr1TWM2OD1zMUKuOFkh|ryPNHO2[VdUSU6JRWK=
NEC8MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkH3TWM2OD1zMUKuOlI1KM7:TR?=NHPIO5VUSU6JRWK=
SIG-M5Mn\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUT5RZAxUUN3ME2xNVMvOTJ3IN88US=>MnO4V2FPT0WU
786-0NHr0SoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fzVmlEPTB;MUGzMlQ2OyEQvF2=M4DKUnNCVkeHUh?=
DMS-273MmnmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mom2TWM2OD1zMUWuOlE4KM7:TR?=M33oTXNCVkeHUh?=
Calu-6NHjnXIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTFzNj63PVgh|ryPM37UbnNCVkeHUh?=
HCC1599MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHG1TGVKSzVyPUGxO{4yPTZizszNNITiRpVUSU6JRWK=
OVCAR-8MoWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPoTWM2OD1zMUeuOlY5KM7:TR?=NID0dI9USU6JRWK=
ATN-1NXPB[Jd6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fUfmlEPTB;MUG3MlgzQCEQvF2=NEX4[mZUSU6JRWK=
RKOMlzoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHOTWM2OD1zMUeuPFk5KM7:TR?=MXXTRW5ITVJ?
SKG-IIIaMnvaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVqxVlllUUN3ME2xNVgvOTF4IN88US=>Mn7lV2FPT0WU
SUP-T1NUXJRYVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDCelF7UUN3ME2xNVgvQTV4IN88US=>NVvmfW1oW0GQR1XS
KNS-81-FDMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTFzOT60NVch|ryPMYjTRW5ITVJ?
OVCAR-3MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYW2SIxkUUN3ME2xNVkvQTF3IN88US=>NUXFd21sW0GQR1XS
NCI-N87M1nTbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWf2e|FjUUN3ME2xNlEvODR2IN88US=>M{TUSnNCVkeHUh?=
HuP-T4MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17nV2lEPTB;MUKxMlU2KM7:TR?=M{\SdHNCVkeHUh?=
KYSE-140MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLNTWM2OD1zMkKuNVQyKM7:TR?=M17S[HNCVkeHUh?=
HAL-01MnHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTKTWM2OD1zMkKuOFk6KM7:TR?=Mm\5V2FPT0WU
HT-29NI[wZnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTPU3lNUUN3ME2xNlIvPzd6IN88US=>MYfTRW5ITVJ?
OPM-2NFLXWIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTF{Mz6xO|Yh|ryPNVLaO2xKW0GQR1XS
SW1463NGPuWlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWniRpVpUUN3ME2xNlQvODd5IN88US=>Mo\HV2FPT0WU
NCI-H2087NFzydIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWPJR|UxRTF{ND6yPFMh|ryPNULw[WF6W0GQR1XS
UMC-11NWDTT2lpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3O4c2lEPTB;MUK2MlA{QCEQvF2=NX7WPVc2W0GQR1XS
EB-3NHP2OVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\RSYlKSzVyPUGyO{4xOTNizszNNUjsWYFpW0GQR1XS
HEC-1NYG4TJNWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTF{OT6xPVgh|ryPMnWwV2FPT0WU
LU-99AMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTF{OT65N|Eh|ryPMW\TRW5ITVJ?
VMRC-RCZNHrPWpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2GyWWlEPTB;MUOwMlM4PSEQvF2=NFvzcoNUSU6JRWK=
MFH-inoMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEmxbYpKSzVyPUGzNU4yOTRizszNMVHTRW5ITVJ?
HT-1080NHrTXmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV;JR|UxRTF|Mj6yNFQh|ryPM2r2fXNCVkeHUh?=
CTB-1Moj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTF|Mj64PVch|ryPNYTE[mZDW0GQR1XS
Capan-2Mn\HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn\kTWM2OD1zM{OuPVc2KM7:TR?=M{Py[XNCVkeHUh?=
BB30-HNCNGTnSXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknGTWM2OD1zM{SuNVE3KM7:TR?=M2rNd3NCVkeHUh?=
CP50-MEL-BNGXUNFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTF|ND6yJO69VQ>?NGnYVWNUSU6JRWK=
JEG-3MnjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jQR2lEPTB;MUO0MlM2QSEQvF2=M3PkRnNCVkeHUh?=
NCI-H1437M3qwVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHtfIFKSzVyPUGzOE42QSEQvF2=NXfneYpFW0GQR1XS
NOS-1NU\oZowzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;QTWM2OD1zM{SuO|Y2KM7:TR?=Mlv6V2FPT0WU
G-402MmmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PaW2lEPTB;MUO1MlI6PSEQvF2=NEn1TGhUSU6JRWK=
OAW-42NYjk[YJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3vjU2lEPTB;MUO3Mlg2PiEQvF2=MlXXV2FPT0WU
Ca-SkiMl;SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{GxZWlEPTB;MUO4Mlg{OSEQvF2=M{T3VHNCVkeHUh?=
BHT-101NFHt[odIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{P0U2lEPTB;MUSwMlIxQCEQvF2=NW\GVVVyW0GQR1XS
OVCAR-4NXPoS|NMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWL1U4c6UUN3ME2xOFAvPzR7IN88US=>NYrUV2gzW0GQR1XS
Detroit562MlvwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVP4WoFFUUN3ME2xOFEvPDZ4IN88US=>NH\UPIlUSU6JRWK=
OCI-AML2NFrKOY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrUWZNlUUN3ME2xOFEvPTB5IN88US=>NELrNFBUSU6JRWK=
OE33MmHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\nNIdKSzVyPUG0NU44QThizszNMWrTRW5ITVJ?
YKG-1NIDy[GhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTF2Mj64PFkh|ryPMVjTRW5ITVJ?
CCF-STTG1NYXaXWJVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zlZmlEPTB;MUSzMlM{PCEQvF2=NGrtUWNUSU6JRWK=
NCI-H810MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NICwXVFKSzVyPUG0N{43QDdizszNNV7SUJIyW0GQR1XS
SCC-25NXG4bW9bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTF2ND6wNFUh|ryPM3r0[HNCVkeHUh?=
HTC-C3NUnZeHNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoGxTWM2OD1zNEWuNFc2KM7:TR?=NHz1PVRUSU6JRWK=
G-401MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLCTWM2OD1zNEWuPFM2KM7:TR?=M3vnT3NCVkeHUh?=
OMC-1NI\sOllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEK3dJVKSzVyPUG0OU46PjdizszNM{PGbHNCVkeHUh?=
LK-2M2D2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTF2Nz6xOFMh|ryPNVH5[m5uW0GQR1XS
SW13NVHFNVJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDYTWM2OD1zNEeuNlU{KM7:TR?=M3LNWnNCVkeHUh?=
BB49-HNCM1;TR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIm5TmlKSzVyPUG0O{41ODRizszNNUP1d|NnW0GQR1XS
DMS-114MojkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlz6TWM2OD1zNEeuOFQyKM7:TR?=MXfTRW5ITVJ?
GCIYMn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTF2Nz63PVch|ryPNHyzUXNUSU6JRWK=
GAMGM{GyTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXtTWM2OD1zNEiuNlQ4KM7:TR?=M3e4U3NCVkeHUh?=
KYSE-520NFrQXlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW[xSm5UUUN3ME2xOFgvPTRizszNM1XGVnNCVkeHUh?=
LB647-SCLCNXO0OYw5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jWN2lEPTB;MUS4MlU3OiEQvF2=NHTSNolUSU6JRWK=
639-VMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFKxZYdKSzVyPUG0PE44ODVizszNMY\TRW5ITVJ?
TE-9MlGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXQPW1KSzVyPUG0PU41PDNizszNNVvFVG95W0GQR1XS
Caov-3MmPrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTF2OT63NVQh|ryPMYnTRW5ITVJ?
L-540MnTQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{S1V2lEPTB;MUS5Mlc2KM7:TR?=M1jqdHNCVkeHUh?=
NCI-H748M1LQXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYWx[VFqUUN3ME2xOVAvOjB7IN88US=>M1zROnNCVkeHUh?=
GDM-1NIT1bHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUHzWG5VUUN3ME2xOVEvOTN3IN88US=>NYPWU3U5W0GQR1XS
GAKM1rk[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTF3MT6zO|Qh|ryPM4fkPXNCVkeHUh?=
AsPC-1MlT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPrTWM2OD1zNUKuO|Y1KM7:TR?=MY\TRW5ITVJ?
MDA-MB-361MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVjkXXZHUUN3ME2xOVMvOTZ2IN88US=>NILyXHVUSU6JRWK=
TTNGr3XnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTF3Mz60PUDPxE1?MonTV2FPT0WU
Calu-1M4LXS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnzRTWM2OD1zNUSuNFA{KM7:TR?=M3LmVHNCVkeHUh?=
RERF-LC-MSM3fpTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MniyTWM2OD1zNUSuO|czKM7:TR?=MYDTRW5ITVJ?
DK-MGM33GZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkjETWM2OD1zNUWuNVg{KM7:TR?=MlfNV2FPT0WU
CAL-120MmrIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTF3NT64NlEh|ryPNUTwfnYyW0GQR1XS
HCC1419NFr4RlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIP1d5dKSzVyPUG1Ok4xPzdizszNMVHTRW5ITVJ?
DG-75MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3sN2xKSzVyPUG1Ok43QTRizszNM2LYe3NCVkeHUh?=
HCC38MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWr0WYsyUUN3ME2xOVcvOzZ7IN88US=>NVvIZpFiW0GQR1XS
HCC70NVrTfnRuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TDemlEPTB;MUW5MlI1OiEQvF2=NXzXVIxSW0GQR1XS
ES4M{nQSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTF3OT6zPVYh|ryPM4nrbHNCVkeHUh?=
NCI-H2052MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3LY[GlEPTB;MUW5MlU5OyEQvF2=M2DnfnNCVkeHUh?=
EFO-27NXz3TJc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3MTWM2OD1zNkCuOVg1KM7:TR?=NIniOlBUSU6JRWK=
CAL-62M3q5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnrTWM2OD1zNkKuOlE{KM7:TR?=MofTV2FPT0WU
CHP-212MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYToZnlQUUN3ME2xOlMvPjJ4IN88US=>NYPYeVM3W0GQR1XS
AU565NIi4enpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfVTWM2OD1zNkOuOlQh|ryPNIHGWJZUSU6JRWK=
Ca9-22NHTBbnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIK5UIhKSzVyPUG2OE4{OjFizszNM{XOU3NCVkeHUh?=
EFO-21MoHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnUS4RKSzVyPUG2OU41PSEQvF2=NGfxNHNUSU6JRWK=
KINGS-1MmDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYHFPG46UUN3ME2xOlcvOzV2IN88US=>MX;TRW5ITVJ?
JVM-2MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPXc|hKSzVyPUG2O{41PTFizszNM1PlZXNCVkeHUh?=
OVCAR-5M{TzV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlmwTWM2OD1zNkiuN|A6KM7:TR?=NITQ[FdUSU6JRWK=
Calu-3MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzZV29KSzVyPUG2PE4{OTFizszNNGD6Xo1USU6JRWK=
CP66-MELNUXpWo1QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHlVIxuUUN3ME2xOlgvPDF3IN88US=>NYHIeHFmW0GQR1XS
KYSE-150M3OycGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTF4OT62N|Yh|ryPNHj4b|JUSU6JRWK=
DaoyM17sPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTF4OT64PVEh|ryPMWfTRW5ITVJ?
HUTU-80MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHzGR3JKSzVyPUG3NU4xOzJizszNNIi3RYVUSU6JRWK=
SW620M2XLfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;xSGlEPTB;MUexMlU{PSEQvF2=MoOyV2FPT0WU
HuO-3N1NWK3XmxlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;0cWtlUUN3ME2xO|IvOjd|IN88US=>NUj2eodKW0GQR1XS
HHNXrU[XJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XxfWlEPTB;MUezMlg1QCEQvF2=MY\TRW5ITVJ?
ME-180MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHS3Um9KSzVyPUG3OE4xOTZizszNMVHTRW5ITVJ?
SW756MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vJUGlEPTB;MUe0Mlg3OyEQvF2=M1m1d3NCVkeHUh?=
LNCaP-Clone-FGCNFjyZ4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlq5TWM2OD1zN{WuPFYyKM7:TR?=NIjUb4dUSU6JRWK=
YTNYfme5FiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXT3SpViUUN3ME2xO|YvOzl7IN88US=>MWPTRW5ITVJ?
EW-3NGq4ZoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoL3TWM2OD1zN{[uOVU2KM7:TR?=NVfQXY44W0GQR1XS
COLO-741MlPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTF5Nz61OlEh|ryPM1XYfnNCVkeHUh?=
SK-NEP-1M17vSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIryNmhKSzVyPUG3O{45ODZizszNMXrTRW5ITVJ?
NB10NGTOO|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mke3TWM2OD1zN{euPFQ3KM7:TR?=MWHTRW5ITVJ?
SF126MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVjJR|UxRTF5OT60N|Ih|ryPM3nINXNCVkeHUh?=
NCI-H522NUXyNmk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\tTIJRUUN3ME2xPFEvODV7IN88US=>NV\2bppJW0GQR1XS
PSN1NYDYfHF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zzfGlEPTB;MUixMlY3KM7:TR?=MVPTRW5ITVJ?
GI-ME-NNGfieGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3fMPWlEPTB;MUixMlY4OiEQvF2=MV3TRW5ITVJ?
SBC-5NWXaNmpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvFTWM2OD1zOEGuPVM1KM7:TR?=NFzaWpZUSU6JRWK=
ONS-76NGXvRWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXzD[JVbUUN3ME2xPFIvOzh5IN88US=>NWTYNJNbW0GQR1XS
LOUCYNEjEZYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjMTWZKSzVyPUG4Nk43QDhizszNM4XaUHNCVkeHUh?=
SN12CMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\0VFlKUUN3ME2xPFIvQDJ7IN88US=>Mmj6V2FPT0WU
A427NYXzepE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTF6ND62N|Eh|ryPNVnOZ|Q{W0GQR1XS
DOKNYXWeZBLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTF6ND62OFMh|ryPM3TGfHNCVkeHUh?=
MDA-MB-415MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLhTWM2OD1zOESuOlUyKM7:TR?=MYLTRW5ITVJ?
MRK-nu-1M4\OeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;zPWlEPTB;MUi0Mlk4OiEQvF2=M3nCNnNCVkeHUh?=
LB2241-RCCNEHjNmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrlTWM2OD1zOEWuNVQ2KM7:TR?=NGHtelFUSU6JRWK=
NCI-H1563NVfsSoVWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYS4R2dsUUN3ME2xPFUvOjB7IN88US=>M3f6W3NCVkeHUh?=
MDA-MB-453Mn3LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrYTWM2OD1zOE[uPVQyKM7:TR?=MoW3V2FPT0WU
MONO-MAC-6NVLxO5ZHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTF6Nz6zPVIh|ryPNGXPd|RUSU6JRWK=
CAPAN-1NYrhNINkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmL5TWM2OD1zOEeuOFU{KM7:TR?=NFLXbHVUSU6JRWK=
SK-LU-1NFv2UXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTF6OD60Nlgh|ryPMmO1V2FPT0WU
NCI-H1299NVPZcFNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkP2TWM2OD1zOEiuO|E6KM7:TR?=M2DrSHNCVkeHUh?=
KG-1NYHvWWhyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLCTWM2OD1zOEmuO|k5KM7:TR?=MVTTRW5ITVJ?
ETK-1NXzDT|RoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYKxZnJ5UUN3ME2xPVAvOThzIN88US=>Mn7XV2FPT0WU
NCI-H838MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXnOYVKUUN3ME2xPVAvOzRizszNNF7PXVBUSU6JRWK=
HCE-4NX7VO2lMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTF7MD65PVIh|ryPM1HtZXNCVkeHUh?=
A2780NWfWc|RZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXhZ3FKSzVyPUG5Nk45QTFizszNMnPFV2FPT0WU
COLO-668M1:zPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXuTWM2OD1zOUOuNVU4KM7:TR?=NWexfGZvW0GQR1XS
HGC-27M{jhcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTF7NT61N|gh|ryPMX7TRW5ITVJ?
SW1088MnX5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MY\JR|UxRTF7NT62O|ch|ryPMW\TRW5ITVJ?
KOSC-2NWrkNFB7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrpTWM2OD1zOUWuPFE5KM7:TR?=Mln3V2FPT0WU
TE-1Mlr4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXtTVY2UUN3ME2xPVYvOjZizszNNH3Ne|BUSU6JRWK=
SW780MlzXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTHdllKSzVyPUG5Ok44OzRizszNM37kNXNCVkeHUh?=
22RV1MlfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4Pz[2lEPTB;MUm3MlQzPCEQvF2=NEX6OHFUSU6JRWK=
IA-LMNVXiOFd[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M371VmlEPTB;MUm3MlgzOiEQvF2=NFHmeIFUSU6JRWK=
TE-5MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTBblF5UUN3ME2xPVgvODN|IN88US=>NIG2fWlUSU6JRWK=
JVM-3MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX:ydHFyUUN3ME2xPVgvPDF7IN88US=>MWjTRW5ITVJ?
HT55MoDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTF7OT6xPVIh|ryPNGDhNY1USU6JRWK=
QIMR-WILNEDuN|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRTJyMD6xNVYh|ryPMV3TRW5ITVJ?
SJRH30MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnfITWM2OD1{MECuOVE2KM7:TR?=MmH1V2FPT0WU
COLO-679M{e1NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPOU25VUUN3ME2yNFAvQDV7IN88US=>NWnqcVA6W0GQR1XS
MDA-MB-231MnPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{DvSmlEPTB;MkCwMlkxOiEQvF2=M3\vTXNCVkeHUh?=
MFM-223M2L0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTJyMT61PFch|ryPNXnjOZFKW0GQR1XS
MFE-280MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;VVWlEPTB;MkCxMlk3OSEQvF2=NFy0U5pUSU6JRWK=
LAMA-84MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUniR3RVUUN3ME2yNFIvODd|IN88US=>MYHTRW5ITVJ?
LS-1034NVfBbmJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XKOGlEPTB;MkCyMlU2OyEQvF2=NYTLb2NyW0GQR1XS
NCI-H345MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3:5[GlEPTB;MkCzMlAzPyEQvF2=MmXOV2FPT0WU
KYSE-70MnXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYHITlE6UUN3ME2yNFMvQDd7IN88US=>M4XlWnNCVkeHUh?=
EGI-1NWruOlE{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HlNWlEPTB;MkC0Mlg{OyEQvF2=M{juUHNCVkeHUh?=
RPMI-2650NWfPfZJRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTJyNT60Olch|ryPM1\nfHNCVkeHUh?=
NCI-H1651Ml\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHw[G9KSzVyPUKwOk44OyEQvF2=NY\XW4N1W0GQR1XS
HPAF-IIMkjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVr3[WNjUUN3ME2yNFkvPjdzIN88US=>NFy0UGhUSU6JRWK=
NUGC-3M4jZ[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnJR|UxRTJyOT62O|gh|ryPM3PHO3NCVkeHUh?=
DJM-1MlPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnKzTWM2OD1{MEmuPFk4KM7:TR?=NYrodoJEW0GQR1XS
MHH-PREB-1MkLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHvbVdKSzVyPUKxNE4{QDFizszNMWDTRW5ITVJ?
EW-18MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU[1NYFZUUN3ME2yNVAvPzZ|IN88US=>MkXCV2FPT0WU
BT-20NVvQeHFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH7ofnhKSzVyPUKxNE46QDZizszNNEDzdVhUSU6JRWK=
A431NFPae4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV;JR|UxRTJzMT6yPVkh|ryPMWLTRW5ITVJ?
TCCSUPNH3sRYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTJzMT61N|Mh|ryPMX7TRW5ITVJ?
HO-1-N-1M2rw[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXpTWM2OD1{MUKuPFk1KM7:TR?=NF\SNFNUSU6JRWK=
NCI-H69M2HFbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37ZR2lEPTB;MkG0MlE5PSEQvF2=NH23bYFUSU6JRWK=
ES7Mon4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV;FemJHUUN3ME2yNVQvQDd6IN88US=>NGfFbm1USU6JRWK=
C3AM4LHSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTJzNT61O|Uh|ryPNIrWbm5USU6JRWK=
UACC-257Ml3sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYTQPZJqUUN3ME2yNVcvPDNizszNNIDxXlBUSU6JRWK=
DMS-153NIm2NZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPpclBKSzVyPUKxO{45OzZizszNNWjqR4YzW0GQR1XS
LB771-HNCMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH6zNVhKSzVyPUKxO{45QTNizszNMlLlV2FPT0WU
HOSMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEO2bFNKSzVyPUKxPE46KM7:TR?=NH\KXnlUSU6JRWK=
THP-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofjTWM2OD1{MUmuOlA3KM7:TR?=MWXTRW5ITVJ?
SCC-4NIT4NmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInx[4pKSzVyPUKyNE4{PTNizszNNUHsXItpW0GQR1XS
SCC-3NVyzbpFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPETWM2OD1{MkCuOVc4KM7:TR?=MorVV2FPT0WU
BC-1M4\1XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1TGNWlEPTB;MkKwMlc6QSEQvF2=NEXmboxUSU6JRWK=
NCI-H1618NXzE[WpPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEj3W5pKSzVyPUKyNU4xOThizszNNV\l[I1UW0GQR1XS
CaR-1NX7ie4w6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTJ{MT6yOVEh|ryPMl;qV2FPT0WU
NCI-H1355MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTJ{MT6zO|ch|ryPMWLTRW5ITVJ?
NCI-H1993NU\xenM6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4DHU2lEPTB;MkKyMlI{QSEQvF2=NXHKPYQ3W0GQR1XS
NCI-H1623MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDq[pZKSzVyPUKyNk4{QDlizszNMljyV2FPT0WU
AGSMknKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTJ{Mj61NlMh|ryPNFGyfpNUSU6JRWK=
SASNXnCfGRET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFzjZnpKSzVyPUKyN{44QTZizszNNXnH[YVtW0GQR1XS
HCC1937M2LpUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHjTWM2OD1{MkSuN|g6KM7:TR?=NVyzSYNmW0GQR1XS
NCI-H209MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXCTWM2OD1{Mk[uOVMh|ryPMYDTRW5ITVJ?
NCI-H322MNXfafJdOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTkTWM2OD1{MkiuNFE6KM7:TR?=MUHTRW5ITVJ?
CHL-1M3vyNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTJ{OD6xN{DPxE1?Mkf5V2FPT0WU
NCI-H630M1fae2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHPIW5ZKSzVyPUKzNk45QTdizszNMWTTRW5ITVJ?
5637Mkj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmH3TWM2OD1{M{OuNFA{KM7:TR?=MlT4V2FPT0WU
MSTO-211HM37Jbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NISyWnlKSzVyPUKzN{4zPzZizszNMXTTRW5ITVJ?
YAPCMkP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn:0TWM2OD1{M{SuNlU{KM7:TR?=NWPmcIU{W0GQR1XS
SW1783M2n0XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDtXI1nUUN3ME2yN|QvPDFizszNNXn2dG5VW0GQR1XS
GB-1MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVrK[FJPUUN3ME2yN|UvOTd5IN88US=>NXnVcWtQW0GQR1XS
NCI-H520NF:1TmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXm0eHN[UUN3ME2yN|UvPzRzIN88US=>M1TvNnNCVkeHUh?=
NOMO-1NUeycWY3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTJ|Nj6wNkDPxE1?NGLwTmNUSU6JRWK=
NCCITM{nWRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M17JdGlEPTB;MkO2Mlg4OyEQvF2=MmjYV2FPT0WU
SW954NHX4[WFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUX3SpA1UUN3ME2yN|cvQDZ6IN88US=>NWjLe21IW0GQR1XS
MOLT-4NV3OUodDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnXPJBKSzVyPUK0NU4zODlizszNMlrBV2FPT0WU
EB2MmGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2LPb2lEPTB;MkSxMlkxPyEQvF2=M{POTHNCVkeHUh?=
IPC-298NHruVm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTJ2Mj6wO|Ih|ryPMnPyV2FPT0WU
GP5dNFvuVJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1H4bGlEPTB;MkSyMlYyPiEQvF2=NXrzcnd3W0GQR1XS
HNNEfD[GxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXzhV5lrUUN3ME2yOFIvQTlzIN88US=>NUTtWGRCW0GQR1XS
BFTC-909M1;He2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGP5fnNKSzVyPUK0N{4yOThizszNMmHTV2FPT0WU
ES5Ml3rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\zTWM2OD1{NEWuNFM5KM7:TR?=NVXhNG5jW0GQR1XS
SK-HEP-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLpPHdKSzVyPUK0Ok4xPDNizszNM4jhenNCVkeHUh?=
T47DMoDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHvSoo5UUN3ME2yOFcvODF|IN88US=>M4riU3NCVkeHUh?=
KYSE-510MnfoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4j5XGlEPTB;MkS3MlUyPyEQvF2=M{PVUXNCVkeHUh?=
LC-1FMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M164WGlEPTB;MkS4MlE2PiEQvF2=MUXTRW5ITVJ?
NCI-H1693NYC1boJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PxdGlEPTB;MkS5MlQ6PSEQvF2=MlHRV2FPT0WU
COR-L23NH34NItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvmTWM2OD1{NUCuOFEzKM7:TR?=NUm5VJp2W0GQR1XS
NCI-H2228MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTJ3MD64OlQh|ryPNWrmS4tiW0GQR1XS
NCI-H460MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4D0R2lEPTB;MkWxMlQyPyEQvF2=Mn3sV2FPT0WU
TGBC1TKBMl6yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLzN29{UUN3ME2yOVIvQDd3IN88US=>MlziV2FPT0WU
NCI-H1304NGX4WJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTJ3Mz6xOVYh|ryPNG\CdFVUSU6JRWK=
CAL-27NX21OnRJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\PTWM2OD1{NUOuOFg2KM7:TR?=M4PJNHNCVkeHUh?=
NCI-H187NVvpOlZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIf2NIZKSzVyPUK1Ok44PiEQvF2=NF;FcnhUSU6JRWK=
HSC-2NWCzWYRvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XpZWlEPTB;MkW4MlU5PCEQvF2=M2HmfXNCVkeHUh?=
CAL-39MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MorvTWM2OD1{NkCuNlczKM7:TR?=MmfjV2FPT0WU
HuH-7M1OxNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnaTWM2OD1{NkCuPVk3KM7:TR?=MoDVV2FPT0WU
MMAC-SFM{\rXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHjOINuUUN3ME2yOlEvOTl{IN88US=>MmXDV2FPT0WU
VA-ES-BJMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWnXdlhjUUN3ME2yOlEvQTF6IN88US=>MWPTRW5ITVJ?
A673M{jxb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTJ4Nz6wNlUh|ryPNG[4XXVUSU6JRWK=
LU-165M4Dye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M17tPGlEPTB;Mk[3Mlk1OSEQvF2=MnrGV2FPT0WU
CAL-12TNX7Wc2F4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn3xTWM2OD1{NkiuN|Y3KM7:TR?=MVTTRW5ITVJ?
RDNH3PbJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1Xic2lEPTB;Mk[5MlEyQSEQvF2=MoTXV2FPT0WU
MDA-MB-468MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoLsTWM2OD1{NkmuN|M{KM7:TR?=NFfZe4tUSU6JRWK=
LN-405NF31OVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1H4N2lEPTB;Mk[5MlcxQCEQvF2=MVvTRW5ITVJ?
MHH-CALL-2MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfmbFd1UUN3ME2yOlkvQTJizszNMoW4V2FPT0WU
ES3MkHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnu0TWM2OD1{N{CuN|U5KM7:TR?=M4LRT3NCVkeHUh?=
SK-MEL-3MlXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVLjWmF2UUN3ME2yO|UvPDV5IN88US=>MlHtV2FPT0WU
TE-10MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPFXnlKSzVyPUK3Ok41OzlizszNMVXTRW5ITVJ?
BENNHvyTXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFXUVXdKSzVyPUK3Ok41PjFizszNNXfzWYdDW0GQR1XS
NB69M4[5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTJ5Nz60NFUh|ryPMVnTRW5ITVJ?
CAMA-1NFzifGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mo[5TWM2OD1{N{iuNlc6KM7:TR?=NEmyUVJUSU6JRWK=
NCI-H1792NFv5TIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTGW3hUUUN3ME2yO|kvOTh5IN88US=>MUPTRW5ITVJ?
UACC-893MljKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTJTWM2OD1{OECuOVQh|ryPMV7TRW5ITVJ?
TGWMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF[1cYlKSzVyPUK4N{4xPThizszNNYXkbXpoW0GQR1XS
SH-4MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTJ6Mz6xNlMh|ryPNUTYZnpjW0GQR1XS
NCI-H2009M4DucWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTJ6Mz65OVMh|ryPMnXyV2FPT0WU
T84NVnFXZNkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2noO2lEPTB;Mki0MlY3PSEQvF2=M3jtbnNCVkeHUh?=
EW-7NGHG[mxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;TTWM2OD1{OEWuNlMzKM7:TR?=M3TYfnNCVkeHUh?=
NCI-H1882MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV\PXGZyUUN3ME2yPFYvODN3IN88US=>NV3RfoVrW0GQR1XS
GMS-10MlXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\SRmlEPTB;Mki3MlE5OyEQvF2=MXTTRW5ITVJ?
HC-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTJ7MD62NFIh|ryPNUm4UJhCW0GQR1XS
ABC-1NIL4eJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTJ7MT6wOlkh|ryPNXLySHpVW0GQR1XS
HuP-T3M4nmcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTJ7Mj6xOFYh|ryPNEfhUohUSU6JRWK=
HT-1197MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVO2fotzUUN3ME2yPVIvQDd7IN88US=>M3TXS3NCVkeHUh?=
SHP-77NX64WFhiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnH3TWM2OD1{OUWuOVk4KM7:TR?=NWXifmx4W0GQR1XS
NCI-H524M3jWb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfRfZNKSzVyPUK5OU44PjlizszNNYn0bnU2W0GQR1XS
SW626MoHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnryTWM2OD1{OU[uNVE2KM7:TR?=M2r3NnNCVkeHUh?=
NCI-H2347NH;2dWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIjCNJRKSzVyPUK5Ok41OjVizszNM4SyUnNCVkeHUh?=
U251NGnpXXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnj4TWM2OD1{OUiuOFM5KM7:TR?=MlnZV2FPT0WU
RL95-2M3v6ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoraTWM2OD1|MECuNlQ4KM7:TR?=NVzKUZNDW0GQR1XS
C2BBe1NX3td2RxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zrUGlEPTB;M{CwMlY6OSEQvF2=MVXTRW5ITVJ?
HLEMoPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3XGdWlEPTB;M{CxMlgyQCEQvF2=NVfzW|ZNW0GQR1XS
COLO-680NNHX1PW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGK2[41KSzVyPUOwNk45QTNizszNNWX1S21DW0GQR1XS
PLC-PRF-5M4fR[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWjqeHhiUUN3ME2zNFQvQTB5IN88US=>NWewc|hTW0GQR1XS
SCC-15NHrwUYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjkVlJtUUN3ME2zNFYvODF5IN88US=>MlrEV2FPT0WU
ECC12M{\NfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3RTWM2OD1|MUCuNlU1KM7:TR?=MWnTRW5ITVJ?
A388MkPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnUTWM2OD1|MUKuNFIzKM7:TR?=M{XGeXNCVkeHUh?=
ES1NXvOb5M{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFv2bIRKSzVyPUOxNk4yQDlizszNMoHqV2FPT0WU
J-RT3-T3-5MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\2b3dmUUN3ME2zNVMvPTJzIN88US=>MmLJV2FPT0WU
SNU-475NInWbmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7RXGhKSzVyPUOxOE4xQTFizszNNITCV|JUSU6JRWK=
647-VNVnrbHdpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\OTWM2OD1|MUSuOlc{KM7:TR?=MmfGV2FPT0WU
IMR-5MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4\IOmlEPTB;M{G1MlM5KM7:TR?=M3rJS3NCVkeHUh?=
EW-24MkL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rZ[mlEPTB;M{KwMlA4KM7:TR?=M4HVO3NCVkeHUh?=
CAL-51M{Th[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnDXY1UUUN3ME2zNlEvPDB|IN88US=>NYPafZV6W0GQR1XS
HD-MY-ZNIC5b2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:5[WpKSzVyPUOyNU41ODlizszNMl:wV2FPT0WU
EW-13NVqwNnNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4rWUGlEPTB;M{KyMlQzPCEQvF2=MXjTRW5ITVJ?
SK-N-FIM3XIOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:3e2Q2UUN3ME2zNlIvPDV{IN88US=>NHTVVlJUSU6JRWK=
BHYMlHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoDQTWM2OD1|MkOuNVc2KM7:TR?=Mlv5V2FPT0WU
OCUB-MMlmyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYO1VZVsUUN3ME2zNlMvPDN2IN88US=>MmXOV2FPT0WU
HCC1954MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV:zZ|BZUUN3ME2zNlMvPTh{IN88US=>NVfP[Xc1W0GQR1XS
SK-MEL-24M{TJNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHYTYhKSzVyPUOyOE4yOTFizszNM{Xq[nNCVkeHUh?=
NTERA-S-cl-D1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTN{Nj60PFkh|ryPMVHTRW5ITVJ?
SK-MEL-30NHHYNnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFXmOWtKSzVyPUOyOk44OzhizszNM1TmbHNCVkeHUh?=
LS-123MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NG\zVlJKSzVyPUOyPE4yPjRizszNMX;TRW5ITVJ?
SF268NIPnTHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGD2[lZKSzVyPUOzNE4zPjVizszNM1rzXnNCVkeHUh?=
BT-474Mn\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPhTWM2OD1|M{KuOFE5KM7:TR?=MmHPV2FPT0WU
NCI-H1522NFLDWotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXX5dWVYUUN3ME2zN|QvOzN7IN88US=>NUjpWIdzW0GQR1XS
LC-2-adNHm1[GhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mo\OTWM2OD1|M{[uOVkyKM7:TR?=NWnVN|ZqW0GQR1XS
LAN-6M3XuZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLFXGJGUUN3ME2zN|YvQTd5IN88US=>M1;VT3NCVkeHUh?=
ARH-77MorlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTN|Nz6zNkDPxE1?MUjTRW5ITVJ?
HuO9M{HOOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTN|Nz60O{DPxE1?NX35TVh3W0GQR1XS
MLMANUK5U4VLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M37GTmlEPTB;M{O4MlE2PSEQvF2=MoTHV2FPT0WU
RajiNIXEXVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\0SmlEPTB;M{O4MlM5KM7:TR?=NVL5b2lYW0GQR1XS
GT3TKBM4Pl[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnJVVFKSzVyPUOzPE41OTJizszNMVzTRW5ITVJ?
NCI-H441MkiwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{D1UGlEPTB;M{SxMlQyQCEQvF2=NFz5OmdUSU6JRWK=
NCI-H2030MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHk[VRpUUN3ME2zOFEvPjB7IN88US=>NXPKU3BEW0GQR1XS
VM-CUB-1MkjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHrTWM2OD1|NEKuOlM3KM7:TR?=MVPTRW5ITVJ?
KP-4MoG2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\2b3Z4UUN3ME2zOFMvPzN|IN88US=>M3\T[HNCVkeHUh?=
PF-382Ml7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTN2ND60NlIh|ryPNID5NpZUSU6JRWK=
NB13NVfFOnZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWj6OnVuUUN3ME2zOFUvPThizszNMX3TRW5ITVJ?
D-502MGNWW5[3RWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIXGNFdKSzVyPUO0OU45OTJizszNNF:2eFBUSU6JRWK=
CAL-54MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlvwTWM2OD1|NEWuPFc6KM7:TR?=NFjvcZhUSU6JRWK=
DOHH-2Mn;RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTN2Nj62OUDPxE1?MVXTRW5ITVJ?
SK-PN-DWNG[4NIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGDvTJJKSzVyPUO0O{41OjZizszNMX3TRW5ITVJ?
NCI-H720NYfyPIJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PIbGlEPTB;M{S5Mlg1PiEQvF2=NH\KbmRUSU6JRWK=
SW1990MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHfVOodKSzVyPUO1NU4zQCEQvF2=NF3NTIpUSU6JRWK=
NCI-H2196NVm3RYs4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTN3Mj62NlQh|ryPNXy3dmlDW0GQR1XS
P30-OHKMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHfkRphKSzVyPUO1N{4xPjNizszNMWTTRW5ITVJ?
NCI-H358MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jyWWlEPTB;M{W1MlM2PiEQvF2=M321R3NCVkeHUh?=
CW-2NUfZPJlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWL0dG9lUUN3ME2zOVYvPTJ7IN88US=>NYHPWFlGW0GQR1XS
COLO-678NVLBWG5JT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvE[4VKSzVyPUO1O{45PjNizszNNIe2Z2NUSU6JRWK=
NCI-H2126Mlu5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVKyR5Z1UUN3ME2zOVgvPTJzIN88US=>M3LwbnNCVkeHUh?=
DMS-53M2XnTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVTuRVZiUUN3ME2zOVgvPzFzIN88US=>NE[2NmRUSU6JRWK=
NCI-H1838MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4POe2lEPTB;M{W5Mlk5PyEQvF2=NF6yXpJUSU6JRWK=
SJSA-1Ml\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{[yfWlEPTB;M{[wMlk{QSEQvF2=Mlj2V2FPT0WU
ChaGo-K-1M2f5[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFP0dXhKSzVyPUO2N{46OjRizszNMkjGV2FPT0WU
IST-SL2Mmf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTN5Mj65NlYh|ryPM{TETnNCVkeHUh?=
U-266MoPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTN5Mz6xN|Ih|ryPNXzreGlbW0GQR1XS
P31-FUJMlfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3q5UmlEPTB;M{e2Mlk3PCEQvF2=NI\YNZNUSU6JRWK=
HCC2157M3PpWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF61Z4FKSzVyPUO3PE4yPjFizszNM4HGWHNCVkeHUh?=
COR-L88MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV\z[ow5UUN3ME2zPFMvPjd5IN88US=>MmH5V2FPT0WU
NCI-H596MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTN6NT6zOEDPxE1?NEPWV2ZUSU6JRWK=
GOTOM2jSemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHxTWM2OD1|OUCuOlQyKM7:TR?=MoPFV2FPT0WU
NCI-H719NIDnbZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;WTWM2OD1|OUGuPFk{KM7:TR?=NVLLSHcxW0GQR1XS
MN-60M{HIe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXfaNXRUUUN3ME2zPVMvQTR6IN88US=>NX\ycmhwW0GQR1XS
IST-SL1NGTXSYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXnTWM2OD1|OUSuOFA3KM7:TR?=M4nvSXNCVkeHUh?=
TE-6NE[zXlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4nRb2lEPTB;M{m3MlI2PCEQvF2=NHHHcWFUSU6JRWK=
SW962Mn7CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLNNZREUUN3ME2zPVgvPjlizszNMmPRV2FPT0WU
FADUMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPWTWM2OD12MEOuNFg{KM7:TR?=MmnUV2FPT0WU
ECC4MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVrKNGJZUUN3ME20NFgvPDV6IN88US=>NUXOeGhzW0GQR1XS
MES-SAMknjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HSVWlEPTB;NEC5Mlk5KM7:TR?=M17vTnNCVkeHUh?=
NCI-H716NFyyZWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjPTWM2OD12MUCuNFc2KM7:TR?=NFfETXdUSU6JRWK=
GR-STNVrSO4QyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DwWmlEPTB;NEGwMlQ6PyEQvF2=NHLrNZNUSU6JRWK=
KY821M3K4Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\XTWM2OD12MUSuNFg3KM7:TR?=MXjTRW5ITVJ?
NCI-H2141NHLHVlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEX2PGNKSzVyPUSyOE4{QDhizszNMlTGV2FPT0WU
MDA-MB-134-VIMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFW5ZlJKSzVyPUSzNU4xOzNizszNM4CycHNCVkeHUh?=
RH-1MnS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXz6R|JDUUN3ME20N|UvODlizszNMl\rV2FPT0WU
AM-38NVzqe3FCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFPPcXdKSzVyPUSzPE42PCEQvF2=M3nn[nNCVkeHUh?=
BL-70MmW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\BWmlEPTB;NEO5MlQzQSEQvF2=NV:0WGN{W0GQR1XS
COLO-684MnS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPETWM2OD12NEiuPFg5KM7:TR?=NYO2cXVTW0GQR1XS
DMS-79NIXqNFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoPYTWM2OD12NEmuOlgh|ryPMVnTRW5ITVJ?
EW-1M{PJdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrPfoduUUN3ME20OVIvQDh6IN88US=>MkT1V2FPT0WU
MS-1NF3wbIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rDemlEPTB;NEW0MlM5PSEQvF2=Mo\lV2FPT0WU
A4-FukM3PNR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M33hTGlEPTB;NEW0MlUxPyEQvF2=Mlq5V2FPT0WU
TALL-1NFrac2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nrXGlEPTB;NEW1MlI6PyEQvF2=MV;TRW5ITVJ?
SCLC-21HM1TqRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3UNINKSzVyPUS1OU43QTlizszNMmDnV2FPT0WU
KMS-12-PENFjlbW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTR3Nj64NlIh|ryPMmjZV2FPT0WU
TE-441-TM1L1OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HDUGlEPTB;NEW3MlE5PiEQvF2=MXPTRW5ITVJ?
A3-KAWMnTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\wSppDUUN3ME20OlAvQDRzIN88US=>M4jVPHNCVkeHUh?=
NCI-H1092MkPFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrMbVdKSzVyPUS2N{46PDNizszNM4OyVnNCVkeHUh?=
COR-L279M1O5XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHKTWM2OD12NkSuPFQ4KM7:TR?=Mnq4V2FPT0WU
NCI-SNU-5MkfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUTEZm9zUUN3ME20O|IvOjhizszNMonIV2FPT0WU
JARNFS4O21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTR5ND63PFgh|ryPMYjTRW5ITVJ?
NCI-H446NUPPNWN7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH31dHRKSzVyPUS3O{4xQCEQvF2=MoHiV2FPT0WU
HDLM-2M{TPb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHVTWM2OD12OECuPFY6KM7:TR?=MkX4V2FPT0WU
D-283MEDMni5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVHJR|UxRTR6OD65NlQh|ryPM3Lw[3NCVkeHUh?=
NCI-H1395NHKxcJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NID3OYRKSzVyPUS4PU4xODRizszNNVLwb2Q{W0GQR1XS
RPMI-6666MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzFTWM2OD12OUGuN|k5KM7:TR?=M3zhd3NCVkeHUh?=
CPC-NM2PSNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTLPJhKSzVyPUWwNk4xPjNizszNNXzr[mFVW0GQR1XS
EC-GI-10M2LlXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\nZYRKSzVyPUWwNk4yPjlizszNM4rXVHNCVkeHUh?=
CA46M1HGbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWf5ZoE{UUN3ME21NFQvPDB5IN88US=>M{fGXHNCVkeHUh?=
EHEBM2jrVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1T0RWlEPTB;NUC3MlIxQCEQvF2=MWrTRW5ITVJ?
RPMI-8402NVnL[IZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnWZoRKUUN3ME21NVAvODJzIN88US=>NVq3WFdFW0GQR1XS
DU-4475NF7QbItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRTVzMT6xNFEh|ryPM13lOHNCVkeHUh?=
P12-ICHIKAWANVTkOGZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTVzMT60NVYh|ryPM3PJVHNCVkeHUh?=
NCI-H1694MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4m1NWlEPTB;NUGyMlQ{QSEQvF2=MkmwV2FPT0WU
NCI-H2171MonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTVzMj63NFUh|ryPMUDTRW5ITVJ?
Mo-TMonFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVnkR|ZxUUN3ME21NVUvOTF4IN88US=>M2DnWHNCVkeHUh?=
HL-60M4jNb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlHmTWM2OD13MkKuPVI1KM7:TR?=NHjLNmpUSU6JRWK=
NCI-H1436M1roPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojwTWM2OD13MkOuNFY1KM7:TR?=NGL5SmlUSU6JRWK=
NCI-H510AM1mxTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnpeGpKSzVyPUWyOE43QTZizszNNG\ycFJUSU6JRWK=
NCI-H2081NHj5[4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1:z[2lEPTB;NUK1MlUyOyEQvF2=NHPEN21USU6JRWK=
NB5MoXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrMTWM2OD13Mk[uOFMh|ryPMmTQV2FPT0WU
NCI-H2227MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTV|MD6yOVQh|ryPNIWydoVUSU6JRWK=
HSC-4NGDve3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVvlTGlkUUN3ME21N|kvOjl|IN88US=>NYf1Tm9VW0GQR1XS
RLNEHWfIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1G3bWlEPTB;NUSyMlQ1OiEQvF2=NITmSG9USU6JRWK=
EVSA-TM3ewbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrVNHJTUUN3ME21OFMvPjh2IN88US=>MUHTRW5ITVJ?
NCI-H889M4HETGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M17B[GlEPTB;NUS3MlI{KM7:TR?=M3rYeHNCVkeHUh?=
COLO-320-HSRNEPBcIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHFTWM2OD13NUGuN|Uh|ryPMmPyV2FPT0WU
EW-11MonSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrWTWM2OD13NUKuN|k6KM7:TR?=M2TSNHNCVkeHUh?=
UACC-812M1vqXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTVRoFKSzVyPUW1PU4{QTFizszNMUDTRW5ITVJ?
CAL-148NYLjdpZQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHiTWM2OD13NkWuNFg6KM7:TR?=NHrpelFUSU6JRWK=
K052M{jaT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDjcGE3UUN3ME21O|kvOjF|IN88US=>M3q2fnNCVkeHUh?=
L-428MmW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTZyMD62O|Eh|ryPM2nReHNCVkeHUh?=
LP-1MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\sTWM2OD14MEOuOVg4KM7:TR?=MkTwV2FPT0WU
ML-2M3nVNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILRXJZKSzVyPU[wOk42PzlizszNMn;zV2FPT0WU
KARPAS-45NYTSWXBRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TjUGlEPTB;NkG4MlIzOSEQvF2=MUPTRW5ITVJ?
HTMoiyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MljnTWM2OD14MkKuO|g2KM7:TR?=MmLhV2FPT0WU
NCI-H226MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\hSHBkUUN3ME22NlgvOzV|IN88US=>NWPTdJBFW0GQR1XS
L-363MoDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;BSmlEPTB;NkS4MlA3PCEQvF2=M3vtbHNCVkeHUh?=
IM-9M4\yNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mln6TWM2OD14NUGuOVQyKM7:TR?=MmXmV2FPT0WU
TURNXX5XY5ET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;obYJKSzVyPU[3NU4{OjJizszNNFv2e2JUSU6JRWK=
NCI-SNU-16NIqzUWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fQfmlEPTB;NkiwMlQ3OiEQvF2=NXm3cnZvW0GQR1XS
NCI-SNU-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHSUZRvUUN3ME22PVAvOTd{IN88US=>MU\TRW5ITVJ?
U-87-MGMm\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TseWlEPTB;Nkm0MlU5PSEQvF2=NGq3SIpUSU6JRWK=
KM-H2M4PhW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVG0WGdMUUN3ME22PVkvODV7IN88US=>M1jVfHNCVkeHUh?=
DELMmDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M13HSGlEPTB;N{CwMlg{QCEQvF2=NYH3N|V1W0GQR1XS
KARPAS-422NG\1bXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvDTWM2OD15OEmuN|E2KM7:TR?=MWjTRW5ITVJ?
BC-3MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEfkSnpKSzVyPUiwOU4zODNizszNMmPlV2FPT0WU
NCI-H1155NFfVToxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPFWFhoUUN3ME24NVgvODV7IN88US=>NXnCN3Z6W0GQR1XS
NCI-H1581NH;CbXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmLITWM2OD17MECuNlMyKM7:TR?=MX7TRW5ITVJ?

... Click to View More Cell Line Experimental Data

In vivo Oral administration of CHIR-99021 at 30 mg/kg enhances glucose metabolism in a rodent model of type 2 diabetes, with a maximal plasma glucose reduction of nearly 150 mg/dl 3-4 hours after administration, while plasma insulin remains at or below control levels. Oral administration of CHIR-99021 at 16 or 48 mg/kg 1 hour before oral glucose challenges in ZDF rats significantly improves glucose tolerance with 14% and 33% reduction in plasma glucose at 16 mg/kg and 48 mg/kg, respectively, and the higher dose of CHIR-99021 also reduces hyperglycemia before the oral glucose challenge. [1] Administration of CHIR-99021 significantly augments hematopoietic repopulation in recipient mice transplanted with mouse or human hematopoietic stem cells (HSCs), suggesting that GSK-3 is a specific modulator of HSC activity. [4]
Features

Protocol(Only for Reference)

Kinase Assay:

[1]

Cell-free kinase assays Polypropylene 96-well plates are filled with 300 μL/well buffer (50 mM tris HCl, 10 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 25 mM β-glycerophosphate, 1 mM NaF, 0.01% BSA, pH 7.5) containing 27 nM GSK-3α or 29 nM GSK-3β, and 0.5 μM biotin-CREB peptide substrate. Various concentrations of CHIR-99021 are added in 3.5 μL of DMSO, followed by 50 μL of ATP stock to yield a final concentration of 1 μM ATP in all cell-free assays. After incubation, triplicate 100-μL aliquots are transferred to Combiplate eight plates containing 100 μL/well 50 μM ATP and 20 mM EDTA. After 1 hour, the wells are rinsed five times with PBS, filled with 200 μL of scintillation fluid, sealed, left 30 minutes, and counted in a scintillation counter. All steps are performed at room temperature.

Cell Assay:

[3]

Cell lines INS-1E
Concentrations Dissolved in DMSO, final concentrations ~ 20 μM
Incubation Time 1, or 4 days
Method

Cells are maintained for 24 hours in starvation medium (culture medium with only 5 mM glucose, 1% fetal calf serum). Then cells are exposed to various concentrations of CHIR-99021 for 1, or 4 days. Cell number is measured by staining of cellular DNA with CyQuant dye, which becomes fluorescent when bound to DNA. Fluorescence is measured after 30 minutes of incubation using the FLUOstar Optima reader. Cell replication is determined by BrdUrd incorporation. BrdUrd labeling solution is added to the medium for the last 4 hours before the cells are fixed using FixDenat solution and incubated with monoclonal anti-BrdUrd-POD antibodies. After substrate solution is added to each well, the light emission is measured in a microplate luminometer using the Analyst HT detection system.

Animal Study:

[1]

Animal Models Female db/db mice or male ZDF rats with type 2 diabetes
Formulation Formulated as solutions in 20 mM citrate-buffered 15% Captisol or as fine suspensions in 0.5% carboxymethylcellulose.
Dosages ~48 mg/kg
Administration Orally

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Ring DB, et al. Diabetes, 2003, 52(3), 588-595.

[2] Bennett CN, et al. J Biol Chem, 2002, 277(34), 30998-31004.

view more

Chemical Information

Download CHIR-99021 (CT99021) HCl SDF
Molecular Weight (MW) 501.8
Formula

C22H18Cl2N8.HCl

CAS No. 252917-06-9 (free base)
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 93 mg/mL (185.33 mM)
Ethanol 2 mg/mL (3.98 mM)
Water <1 mg/mL (<1 mM)
In vivo 15% Captisol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile hydrochloride

Customer Product Validation(7)


Click to enlarge
Rating
Source Proc Natl Acad Sci U S A 2012 109(27):E1848-57. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Immunofluorescent staining
Cell Lines H9-7TGP cells
Concentrations 12 uM
Incubation Time 4 days
Results However, treatment of the H9-7TGP reporter line with the Gsk3 inhibitor CHIR99021 (CH) activated TCF/LEF promoter activity in mTeSR1 on Matrigel. Immunofluorescent analysis revealed that the CH-induced H9-7TGP GFP+ cells did not express Oct4 but did express Isl1 and Nkx2.5.

Click to enlarge
Rating
Source Stem Cells 2012 30, 1863-1874. CHIR-99021 (CT99021) HCl purchased from Selleck
Method beating foci assay
Cell Lines ESCs
Concentrations 1/3uM
Incubation Time 5 d
Results Similarly, inhibition of GSK3 by LiCl [48], by CHIR 99021 [7], or by AR A014418 (a GSK3 inhibitor, which lacks side effects as impairment of cyclin functions [49]), restored the differentiation potential of Gpc4-mutant ESCs to a similar extent.

Click to enlarge
Rating
Source J Biol Chem 2015 290(9), 5592-605 . CHIR-99021 (CT99021) HCl purchased from Selleck
Method Immunofluorescence
Cell Lines PANC1 cells
Concentrations 5 uM
Incubation Time 24 h
Results As shown in D, LC3B puncta were detected in DMSO treated (control) pancreatic cancer cells suggestive of a high degree of autophagy in these cells. This observation is in agreement with a previous report demonstrating an elevated level of autophagy in human pancreatic cancer cell lines that is required for their growth. Despite the high level of basal autophagy, an increased staining of LC3B puncta per cell was observed upon treatment with CHIR99021 or the mTOR inhibitor Torin1 (D), the latter being used as a known inducer of autophagy. For completion of autophagy, the autophagosomes ultimately fuse with lysosomes to ensure the degradation of autophagosomal content. We therefore examined the lysosomal system by performing labeling of these organelles with Lysotracker. CHIR99021 led to an increase in lysosomal staining (E).

Click to enlarge
Rating
Source J Genet Genomics 2012 39, 643e651. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Rat embryoid bodies (rEBs) formation
Cell Lines rES cells
Concentrations 0.75 uM
Incubation Time 4 d
Results For the first 2 days of rEBs formation, rES cells were cultured in CM in the presence of Rho kinase inhibitor, Y-27632 (10 umol/L) and 2i (PD0325901, 0.1 umol/L; CHIR99021, 0.75 umol/L; Selleck, USA). Thereafter, we transferred the regular rEBs into CM supplemented with 2i and without Y-27632 for another 2 days. On day 4, abundant highquality rEBs formed and then 2i was eliminated from the media.

Click to enlarge
Rating
Source PLoS One 2012 7, e47312. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Westernblot
Cell Lines WM793/1205LU
Concentrations 2 uM
Incubation Time 2 h
Results Phoshorylation of β-catenin is decreased and total b-catenin level is slightly increased as a result of CT99021 2-hour treatment.

Click to enlarge
Rating
Source CHIR-99021 (CT99021) HCl purchased from Selleck
Method Western blot
Cell Lines PANC1 cells
Concentrations 5 µM
Incubation Time 72 h
Results prolonged inhibition of GSK3 expression or activity by CHIR99021 correlated with increased levels of cleaved PARP and caspase-7 as well as a 6-fold increase in caspase-3 activity.

Click to enlarge
Rating
Source CHIR-99021 (CT99021) HCl purchased from Selleck
Method Western blot/qRT-PCR analysis
Cell Lines Human lung tissue
Concentrations 0.5/10 μM
Incubation Time 72 h
Results As presented in Figure 6 and B, Western blot analysis showed β-CATENIN expression in 15 W human lung explants decreased significantly from newly isolated to in vitro cultured for 72 h (0 μM). However, β-CATENIN expression nearly increased back to newly isolated levels in human lung explants at 15 W treated with 5 μM CHIR 99021 for 72 h, but decreased again after treatment of 10 μM CHIR 99021. Meanwhile, qRT-PCR analyses showed increased expression of transcription factors (LEF1 , TCF4) and target genes (CYCLIN D1 , MMP7) in human lung explants (15 W) exposed to 5 μM CHIR 99021 compared with tissues exposed to 0 μM CHIR 99021, the levels of which were also higher than in the 10 μM CHIR 99021 groups (Figure C).

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related GSK-3 Products

  • CHIR-99021 (CT99021)

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively.

  • LY2090314

    LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. Phase 2.

  • TDZD-8

    TDZD-8 is a non-ATP competitive GSK-3β inhibitor with IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.

  • TWS119

    TWS119 is a GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; capable of inducing neuronal differentiation and may be useful to stem cell biology.

  • SB216763

    SB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β.

  • Tideglusib

    Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay; fails to inhibit kinases with a Cys homologous to Cys-199 located in the active site. Phase 2.

  • CHIR-98014

    CHIR-98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.

  • BIO

    BIO is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β in a cell-free assay, shows >16-fold selectivity over CDK5, also a pan-JAK inhibitor.

    Features:The first pharmacological agent shown to maintain self-renewal in human and mouse embryonic stem cells.

  • AR-A014418

    AR-A014418 is an ATP-competitive, and selective GSK3β inhibitor with IC50 and Ki of 104 nM and 38 nM in cell-free assays, without significant inhibition on 26 other kinases tested.

  • IM-12

    IM-12 is a selective GSK-3β inhibitor with IC50 of 53 nM, and also enhances canonical Wnt signalling.

Recently Viewed Items

Tags: buy CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl supplier | purchase CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl cost | CHIR-99021 (CT99021) HCl manufacturer | order CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us